DRAGONIERI, SILVANO
 Distribuzione geografica
Continente #
NA - Nord America 8.570
AS - Asia 3.240
EU - Europa 3.003
SA - Sud America 781
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 167
OC - Oceania 57
AN - Antartide 1
Totale 16.239
Nazione #
US - Stati Uniti d'America 8.290
SG - Singapore 1.318
IT - Italia 1.036
CN - Cina 700
BR - Brasile 602
HK - Hong Kong 395
DE - Germania 358
SE - Svezia 358
RU - Federazione Russa 333
VN - Vietnam 221
FR - Francia 211
GB - Regno Unito 206
FI - Finlandia 153
IN - India 125
CA - Canada 121
BD - Bangladesh 117
UA - Ucraina 90
AR - Argentina 63
JP - Giappone 56
AU - Australia 51
CI - Costa d'Avorio 49
IQ - Iraq 49
PL - Polonia 42
ID - Indonesia 40
MX - Messico 40
TR - Turchia 34
ZA - Sudafrica 34
EC - Ecuador 33
NL - Olanda 31
SA - Arabia Saudita 29
CZ - Repubblica Ceca 27
IE - Irlanda 27
VE - Venezuela 27
CR - Costa Rica 25
BE - Belgio 24
ES - Italia 24
PK - Pakistan 22
AT - Austria 21
CO - Colombia 21
UZ - Uzbekistan 21
LT - Lituania 18
PH - Filippine 16
EG - Egitto 15
MA - Marocco 15
MY - Malesia 15
TT - Trinidad e Tobago 15
CW - ???statistics.table.value.countryCode.CW??? 14
SV - El Salvador 12
AE - Emirati Arabi Uniti 11
JM - Giamaica 11
HN - Honduras 10
NI - Nicaragua 10
IL - Israele 9
JO - Giordania 9
KE - Kenya 9
PR - Porto Rico 9
PY - Paraguay 9
GT - Guatemala 8
NP - Nepal 8
PE - Perù 8
SC - Seychelles 8
TN - Tunisia 8
AZ - Azerbaigian 7
CL - Cile 7
ET - Etiopia 7
GP - Guadalupe 7
CH - Svizzera 6
DZ - Algeria 6
KZ - Kazakistan 6
BO - Bolivia 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
UY - Uruguay 5
BS - Bahamas 4
BY - Bielorussia 4
IR - Iran 4
KR - Corea 4
LB - Libano 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
TW - Taiwan 4
AL - Albania 3
BG - Bulgaria 3
EE - Estonia 3
GR - Grecia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
NG - Nigeria 2
TG - Togo 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
Totale 15.814
Città #
Ashburn 1.121
Singapore 735
Fairfield 619
San Jose 577
Chandler 559
Woodbridge 477
Hong Kong 393
Milan 303
Nyköping 286
Houston 284
Seattle 268
Beijing 257
Council Bluffs 250
Ann Arbor 205
Cambridge 205
Jacksonville 199
Wilmington 193
Dallas 185
New York 147
Los Angeles 145
Rome 113
Lauterbourg 106
Santa Clara 95
Roxbury 91
Lawrence 89
Dearborn 88
Bari 83
Munich 82
Nanjing 81
Helsinki 77
São Paulo 70
Boardman 66
Ho Chi Minh City 66
Brooklyn 62
Des Moines 61
Columbus 57
Buffalo 56
Tokyo 54
Abidjan 49
Atlanta 47
Hanoi 45
Perth 43
Chicago 42
Falkenstein 40
Phoenix 38
Figino 35
London 35
Frankfurt am Main 34
Toronto 34
Warsaw 33
Orem 32
Princeton 31
San Diego 31
Inglewood 29
Montreal 29
Jakarta 27
Taranto 25
Dublin 24
Shenyang 24
Brussels 23
Nuremberg 23
Denver 22
Hebei 22
Moscow 22
Olomouc 22
Paris 22
Turin 22
Stockholm 21
Belo Horizonte 20
San José 20
Johannesburg 19
Baghdad 18
Guangzhou 18
Pune 18
Rio de Janeiro 18
Turku 18
Manchester 17
Brasília 16
Dong Ket 16
Poplar 16
Mexico City 15
Turi 15
Amsterdam 14
Chennai 14
Nanchang 14
North Bergen 14
Willemstad 14
Bologna 13
Florence 13
Haiphong 13
Kunming 13
New Delhi 13
Tashkent 13
Hefei 12
Naples 12
San Francisco 12
Washington 12
Da Nang 11
Falls Church 11
Guayaquil 11
Totale 10.204
Nome #
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls 296
Hypercapnia in COPD: Causes, Consequences, and Therapy 273
Voluntary lung function screening to reveal new COPD cases in southern Italy 268
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 210
Biological hazards among meat industry workers 210
Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD 191
Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia 186
An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea 185
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 183
The Role of Gut Bacteriome in Asthma, Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea 178
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 177
Enviromental Asbestos Exposure as a Risk Factor for Small Airways Obstruction 172
Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose 170
Exhaled volatile organic compounds identify patients with colorectal cancer. 169
Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure 166
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 165
[Asbestos and agriculture: new perspectives of risk]. FT Amianto e agricoltura: nuove prospettive di rischio. 164
A case of cryptogenic organizing pneumonia occurring in Crohn's disease 163
Ovarian cycle may influence the exhaled volatile organic compounds profile analyzed by an electronic nose 160
Exposure to NOA in residents: can represent an occupational risk? 158
An electronic nose in the discrimination of patients with asthma and controls 156
Enviromental asbestos exposure as a risk factor for small airways obstruction 151
Does Nocturnal Hypoventilation Have a Protective Effect on Cardiovascular Comorbidity in Obesity Hypoventilation Syndrome? 151
Nocturnal Hypoventilation May Have a Protective Effect on Ischemic Heart Disease in Patients with Obesity Hypoventilation Syndrome 151
A Portable Device as Sleep-Screening Tool in the Identification of Obstructive Sleep Apnea in Chronic Heart Failure: Which Value Should We Consider as Cutoff? 150
The role of education in the self-compilation of Epworth sleepiness scale questionnaire in patients with suspected obstructive sleep apnea 150
Cytogenetic and molecular genetic changes in malignant mesothelioma 149
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial 149
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 149
Airway neutrophilia related to occupational exposure in urban policemen 148
Atrial flutter regression in HIV-associated pulmonary arterial hypertension after treatment with bosentan 147
A new approach for the assessment of sleepiness and predictivity of obstructive sleep apnea in drivers: A pilot study 145
An electronic nose may sniff out amyotrophic lateral sclerosis 143
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD 143
Exhaled breath profiling in patients with COPD and OSA overlap syndrome: A pilot study 143
Tremolite asbestos exposure in a rural area: personal sampling campaign results 138
An electronic nose distinguishes the exhaled breath of obese patients with obstructive sleep apnoea (OSA) from subjects with a similar body mass index and without OSA 136
Using PaCO2 values to grade obesity-hypoventilation syndrome severity: a retrospective study 136
Lack of association between OSAS and Hypothyroidism 134
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma 133
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 132
Chemical characterization of exhaled breath to discriminate patients with Malignant Pleural Mesothelioma from subjects with similar professional asbestos exposure 131
An electronic nose discriminates exhaled breath of patients with untreated Pulmonary Sarcoidosis from controls 131
Electronic Nose Technology in Respiratory Diseases 130
The potential of breath analysis to improve outcome for patients with lung cancer 130
The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase 130
[A case report: an university professor suffering from malignant mesothelioma]. FT Un caso clinico: un professore universitario affetto da mesotelioma maligno. 129
Rischio biologico da Staphylococcus Aureus Meticillino-Resistente nella filiera delle carni 129
Bilateral diaphragmatic paralysis after kidney surgery 127
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 124
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 123
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 123
The Prognostic Role of Obstructive Sleep Apnea at the Onset of Amyotrophic Lateral Sclerosis 123
Sniff Nasal Pressure Is a Sensitive Marker of Poor Outcome in Amyotrophic Lateral Sclerosis 122
The Role of a Polymer-Based E-Nose in the Detection of Head and Neck Cancer from Exhaled Breath 119
Advancing Care in Severe Asthma: The Art of Switching Biologics 118
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 117
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 116
An electronic nose in the diagnostic assessment of asthma in pediatric patients 116
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 115
Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 115
Correlation between nasal inflammation assessed by nasal cytology and blood neutrophil-to-lymphocyte ratio in patients with copd 114
Towards a Better Phenotyping of Chronic Obstructive Pulmonary Diseases 113
Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study 113
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 112
Noninvasive ventilation (NIV) in the management of chronic heart failure (CHF) 111
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia 110
Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients 110
Failure of noninvasive ventilation during hypercapnic exacerbation of chronic obstructive pulmonary disease: the role of chronic kidney diseases 110
A case report: an university professor suffering from malignant mesothelioma. 109
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 106
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 105
PLEURAL MALIGNANT MESOTHELIOMA AMONG RESIDENT POPULATION IN AREAS WITH NATURAL OCCURRING ASBESTOS ON CALABRIA-LUCANIA BORDER 105
Health effects and risk assessment among resident population with naturally occurring asbestos exposure in south of Italy 103
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study 102
The Predictors of Long COVID in Southeastern Italy 97
null 97
Sputum induced cellularity in a group of traffic policemen 97
Occupational asthma in a fruit and vegetables vendor 97
A successfully home-treated adverse reaction to cefepime in a geriatric patient 95
Lower SNIP value is correlated to the need of intubation in Amyotrophic Lateral Sclerosis 95
Influence of circadian rhythm on exhaled breath profiling by electronic nose 95
Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation 94
The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit 93
Asbestos and agriculture: new perspectives of risk 92
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 92
A survey about knowledge of exhaled nitric oxide use among Southern Italian pulmonologists and trainees 92
Asthma and Fixed Airways Obstruction: Real Life Aspects 91
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure 91
Baseline characteristics and outcome predictors in patients hospitalized with COVID-19 in the University General Hospital of Ioannina, Greece 91
Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study 90
Clinical Remission Predictors in Non-Colonized Bronchiectasis and Severe Asthma with Type 2-Targeted Biologic Therapy: A Retrospective Real-Life Pilot Study 90
Breathing rhythm variations during wash-in do not influence exhaled volatile organic compound profile analyzed by an electronic nose 90
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study 88
The role of education in the self-compilation of asthma control test score in patients with asthma 88
Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 87
Divergences in chronic cough management among healthcare professionals in Southern Italy: A comprehensive survey 87
Cytogenetic and molecular genetic changes in malignant mesothelioma. Cancer Genet Cytogenet 87
Negative correlation between respiratory drive and SNIP in amyotrophic lateral sclerosis 86
S-Adenosylmethionine May Mitigate Obstructive Sleep Apnea in an Adult with Down Syndrome: A Case Report 86
Totale 13.157
Categoria #
all - tutte 64.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022578 0 0 0 30 33 78 18 34 43 44 118 180
2022/20231.318 159 157 83 139 126 214 16 159 200 11 30 24
2023/2024602 37 87 31 47 63 146 28 41 6 61 16 39
2024/20252.267 59 34 125 76 73 186 219 255 91 119 357 673
2025/20265.961 836 378 274 532 749 374 574 180 659 534 248 623
2026/20271.812 211 401 448 752 0 0 0 0 0 0 0 0
Totale 16.239